Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells
Abstract Objective A possible role of GH during central nervous system (CNS) development has been suggested by the presence of this hormone and its receptor in brain areas before its production by the pituitary gland. Although several effects have been reported for GH, the specific role of this horm...
Gespeichert in:
Veröffentlicht in: | Growth hormone & IGF research 2013-10, Vol.23 (5), p.179-186 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 186 |
---|---|
container_issue | 5 |
container_start_page | 179 |
container_title | Growth hormone & IGF research |
container_volume | 23 |
creator | Regalado-Santiago, Citlalli López-Meraz, María Leonor Santiago-García, Juan Fernández–Pomares, Cynthia Juárez-Aguilar, Enrique |
description | Abstract Objective A possible role of GH during central nervous system (CNS) development has been suggested by the presence of this hormone and its receptor in brain areas before its production by the pituitary gland. Although several effects have been reported for GH, the specific role of this hormone during CNS development remains unclear. Here, we examined the effect of GH on proliferation, survival and neurosphere formation in primary cultures of striatal tissue from14-day-old (E14) mouse embryos. Design GH receptor gene expression was confirmed by RT-PCR. Primary cultures of embryonic striatal cells were treated with different doses of GH in serum free media, then the number of neurospheres was determined. To examine the GH effect on proliferation and survival of the striatal primary cultures, bromodeoxyuridine (BrdU) and TUNEL immunoreactivity was conducted. Results In the presence of the epidermal growth factor (EGF), GH increased the formation of neurospheres, with a maximal response at 10 ng/ml, higher doses were inhibitory. In absence of EGF, GH failed to stimulate neurosphere formation. Proliferation rate in the primary striatal cultures was inhibited by 24 or 48 h incubation with GH. However, in the absence of EGF, GH increased BrdU incorporation. GH treatment decreases the rate of apoptosis of nestin and GFAP positive cells in the primary striatal cultures, enhancing neurosphere formation. Conclusions Our in vitro data demonstrate that GH plays a survival role on the original population of embryonic striatal cells, improving Neural Precursor Cells (NPCs) expansion. We suggest that this GH action could be predominant during striatal neurodevelopment. |
doi_str_mv | 10.1016/j.ghir.2013.07.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1428272693</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S109663741300066X</els_id><sourcerecordid>1428272693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-45e205812dbcdce6b38798269b36edbafce117e81fcab88928fb176e41cffc6e3</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxSMEoqXwBTggH8shwX-yjiMhpKqCLVIlDoDEzXKcMfGSjZdxsmi_PRNt4cCBgzXW-L2n8W-K4qXgleBCv9lV34eIleRCVbypOJePikuxUbKUUpnHdOetLrVq6oviWc47znmrTP20uKDnVoi2vixwi-nXPLAh4T5NwK63d69ZzMyxvOAxHt3I0M0DIJsHN1H7gGmMAagZj8CC83NCFujAvsNTmqJnecboZnJOsCCVA4JfMJPGwzjm58WT4MYMLx7qVfH1w_svt3fl_aftx9ub-9LXQsxlvQHJN0bIvvO9B90p07RG6rZTGvrOBQ9CNGBE8K4zppUmdKLRUAsfgtegrorrcy6N_HOBPNt9zOsEboK0ZCtqaWRDgYqk8iz1mHJGCPaAce_wZAW3K2u7sytru7K2vLHEmkyvHvKXbg_9X8sfuCR4exYA_fIYAW32ESYPfSQis-1T_H_-u3_sfozE140_4AR5lxaciJ8VNkvL7ed12-uyhaJFa_1N_QalDKct</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428272693</pqid></control><display><type>article</type><title>Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Regalado-Santiago, Citlalli ; López-Meraz, María Leonor ; Santiago-García, Juan ; Fernández–Pomares, Cynthia ; Juárez-Aguilar, Enrique</creator><creatorcontrib>Regalado-Santiago, Citlalli ; López-Meraz, María Leonor ; Santiago-García, Juan ; Fernández–Pomares, Cynthia ; Juárez-Aguilar, Enrique</creatorcontrib><description>Abstract Objective A possible role of GH during central nervous system (CNS) development has been suggested by the presence of this hormone and its receptor in brain areas before its production by the pituitary gland. Although several effects have been reported for GH, the specific role of this hormone during CNS development remains unclear. Here, we examined the effect of GH on proliferation, survival and neurosphere formation in primary cultures of striatal tissue from14-day-old (E14) mouse embryos. Design GH receptor gene expression was confirmed by RT-PCR. Primary cultures of embryonic striatal cells were treated with different doses of GH in serum free media, then the number of neurospheres was determined. To examine the GH effect on proliferation and survival of the striatal primary cultures, bromodeoxyuridine (BrdU) and TUNEL immunoreactivity was conducted. Results In the presence of the epidermal growth factor (EGF), GH increased the formation of neurospheres, with a maximal response at 10 ng/ml, higher doses were inhibitory. In absence of EGF, GH failed to stimulate neurosphere formation. Proliferation rate in the primary striatal cultures was inhibited by 24 or 48 h incubation with GH. However, in the absence of EGF, GH increased BrdU incorporation. GH treatment decreases the rate of apoptosis of nestin and GFAP positive cells in the primary striatal cultures, enhancing neurosphere formation. Conclusions Our in vitro data demonstrate that GH plays a survival role on the original population of embryonic striatal cells, improving Neural Precursor Cells (NPCs) expansion. We suggest that this GH action could be predominant during striatal neurodevelopment.</description><identifier>ISSN: 1096-6374</identifier><identifier>EISSN: 1532-2238</identifier><identifier>DOI: 10.1016/j.ghir.2013.07.002</identifier><identifier>PMID: 23891194</identifier><language>eng</language><publisher>Scotland: Elsevier Ltd</publisher><subject>Advanced Basic Science ; Animals ; Basal Ganglia - cytology ; Basal Ganglia - embryology ; Basal Ganglia - metabolism ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Cells, Cultured ; CNS development ; Embryo, Mammalian ; Endocrinology & Metabolism ; Female ; Growth hormone ; Growth Hormone - pharmacology ; Mice ; Mice, Inbred BALB C ; Neural precursor cells ; Neural Stem Cells - drug effects ; Neural Stem Cells - physiology ; Neurogenesis - drug effects ; Neurogenesis - genetics ; Pregnancy ; Receptors, Somatotropin - genetics ; Striatum</subject><ispartof>Growth hormone & IGF research, 2013-10, Vol.23 (5), p.179-186</ispartof><rights>Elsevier Ltd</rights><rights>2013 Elsevier Ltd</rights><rights>2013.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-45e205812dbcdce6b38798269b36edbafce117e81fcab88928fb176e41cffc6e3</citedby><cites>FETCH-LOGICAL-c411t-45e205812dbcdce6b38798269b36edbafce117e81fcab88928fb176e41cffc6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ghir.2013.07.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27928,27929,45999</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23891194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Regalado-Santiago, Citlalli</creatorcontrib><creatorcontrib>López-Meraz, María Leonor</creatorcontrib><creatorcontrib>Santiago-García, Juan</creatorcontrib><creatorcontrib>Fernández–Pomares, Cynthia</creatorcontrib><creatorcontrib>Juárez-Aguilar, Enrique</creatorcontrib><title>Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells</title><title>Growth hormone & IGF research</title><addtitle>Growth Horm IGF Res</addtitle><description>Abstract Objective A possible role of GH during central nervous system (CNS) development has been suggested by the presence of this hormone and its receptor in brain areas before its production by the pituitary gland. Although several effects have been reported for GH, the specific role of this hormone during CNS development remains unclear. Here, we examined the effect of GH on proliferation, survival and neurosphere formation in primary cultures of striatal tissue from14-day-old (E14) mouse embryos. Design GH receptor gene expression was confirmed by RT-PCR. Primary cultures of embryonic striatal cells were treated with different doses of GH in serum free media, then the number of neurospheres was determined. To examine the GH effect on proliferation and survival of the striatal primary cultures, bromodeoxyuridine (BrdU) and TUNEL immunoreactivity was conducted. Results In the presence of the epidermal growth factor (EGF), GH increased the formation of neurospheres, with a maximal response at 10 ng/ml, higher doses were inhibitory. In absence of EGF, GH failed to stimulate neurosphere formation. Proliferation rate in the primary striatal cultures was inhibited by 24 or 48 h incubation with GH. However, in the absence of EGF, GH increased BrdU incorporation. GH treatment decreases the rate of apoptosis of nestin and GFAP positive cells in the primary striatal cultures, enhancing neurosphere formation. Conclusions Our in vitro data demonstrate that GH plays a survival role on the original population of embryonic striatal cells, improving Neural Precursor Cells (NPCs) expansion. We suggest that this GH action could be predominant during striatal neurodevelopment.</description><subject>Advanced Basic Science</subject><subject>Animals</subject><subject>Basal Ganglia - cytology</subject><subject>Basal Ganglia - embryology</subject><subject>Basal Ganglia - metabolism</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Cells, Cultured</subject><subject>CNS development</subject><subject>Embryo, Mammalian</subject><subject>Endocrinology & Metabolism</subject><subject>Female</subject><subject>Growth hormone</subject><subject>Growth Hormone - pharmacology</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Neural precursor cells</subject><subject>Neural Stem Cells - drug effects</subject><subject>Neural Stem Cells - physiology</subject><subject>Neurogenesis - drug effects</subject><subject>Neurogenesis - genetics</subject><subject>Pregnancy</subject><subject>Receptors, Somatotropin - genetics</subject><subject>Striatum</subject><issn>1096-6374</issn><issn>1532-2238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxSMEoqXwBTggH8shwX-yjiMhpKqCLVIlDoDEzXKcMfGSjZdxsmi_PRNt4cCBgzXW-L2n8W-K4qXgleBCv9lV34eIleRCVbypOJePikuxUbKUUpnHdOetLrVq6oviWc47znmrTP20uKDnVoi2vixwi-nXPLAh4T5NwK63d69ZzMyxvOAxHt3I0M0DIJsHN1H7gGmMAagZj8CC83NCFujAvsNTmqJnecboZnJOsCCVA4JfMJPGwzjm58WT4MYMLx7qVfH1w_svt3fl_aftx9ub-9LXQsxlvQHJN0bIvvO9B90p07RG6rZTGvrOBQ9CNGBE8K4zppUmdKLRUAsfgtegrorrcy6N_HOBPNt9zOsEboK0ZCtqaWRDgYqk8iz1mHJGCPaAce_wZAW3K2u7sytru7K2vLHEmkyvHvKXbg_9X8sfuCR4exYA_fIYAW32ESYPfSQis-1T_H_-u3_sfozE140_4AR5lxaciJ8VNkvL7ed12-uyhaJFa_1N_QalDKct</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Regalado-Santiago, Citlalli</creator><creator>López-Meraz, María Leonor</creator><creator>Santiago-García, Juan</creator><creator>Fernández–Pomares, Cynthia</creator><creator>Juárez-Aguilar, Enrique</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells</title><author>Regalado-Santiago, Citlalli ; López-Meraz, María Leonor ; Santiago-García, Juan ; Fernández–Pomares, Cynthia ; Juárez-Aguilar, Enrique</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-45e205812dbcdce6b38798269b36edbafce117e81fcab88928fb176e41cffc6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Advanced Basic Science</topic><topic>Animals</topic><topic>Basal Ganglia - cytology</topic><topic>Basal Ganglia - embryology</topic><topic>Basal Ganglia - metabolism</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Cells, Cultured</topic><topic>CNS development</topic><topic>Embryo, Mammalian</topic><topic>Endocrinology & Metabolism</topic><topic>Female</topic><topic>Growth hormone</topic><topic>Growth Hormone - pharmacology</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Neural precursor cells</topic><topic>Neural Stem Cells - drug effects</topic><topic>Neural Stem Cells - physiology</topic><topic>Neurogenesis - drug effects</topic><topic>Neurogenesis - genetics</topic><topic>Pregnancy</topic><topic>Receptors, Somatotropin - genetics</topic><topic>Striatum</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Regalado-Santiago, Citlalli</creatorcontrib><creatorcontrib>López-Meraz, María Leonor</creatorcontrib><creatorcontrib>Santiago-García, Juan</creatorcontrib><creatorcontrib>Fernández–Pomares, Cynthia</creatorcontrib><creatorcontrib>Juárez-Aguilar, Enrique</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Growth hormone & IGF research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Regalado-Santiago, Citlalli</au><au>López-Meraz, María Leonor</au><au>Santiago-García, Juan</au><au>Fernández–Pomares, Cynthia</au><au>Juárez-Aguilar, Enrique</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells</atitle><jtitle>Growth hormone & IGF research</jtitle><addtitle>Growth Horm IGF Res</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>23</volume><issue>5</issue><spage>179</spage><epage>186</epage><pages>179-186</pages><issn>1096-6374</issn><eissn>1532-2238</eissn><abstract>Abstract Objective A possible role of GH during central nervous system (CNS) development has been suggested by the presence of this hormone and its receptor in brain areas before its production by the pituitary gland. Although several effects have been reported for GH, the specific role of this hormone during CNS development remains unclear. Here, we examined the effect of GH on proliferation, survival and neurosphere formation in primary cultures of striatal tissue from14-day-old (E14) mouse embryos. Design GH receptor gene expression was confirmed by RT-PCR. Primary cultures of embryonic striatal cells were treated with different doses of GH in serum free media, then the number of neurospheres was determined. To examine the GH effect on proliferation and survival of the striatal primary cultures, bromodeoxyuridine (BrdU) and TUNEL immunoreactivity was conducted. Results In the presence of the epidermal growth factor (EGF), GH increased the formation of neurospheres, with a maximal response at 10 ng/ml, higher doses were inhibitory. In absence of EGF, GH failed to stimulate neurosphere formation. Proliferation rate in the primary striatal cultures was inhibited by 24 or 48 h incubation with GH. However, in the absence of EGF, GH increased BrdU incorporation. GH treatment decreases the rate of apoptosis of nestin and GFAP positive cells in the primary striatal cultures, enhancing neurosphere formation. Conclusions Our in vitro data demonstrate that GH plays a survival role on the original population of embryonic striatal cells, improving Neural Precursor Cells (NPCs) expansion. We suggest that this GH action could be predominant during striatal neurodevelopment.</abstract><cop>Scotland</cop><pub>Elsevier Ltd</pub><pmid>23891194</pmid><doi>10.1016/j.ghir.2013.07.002</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1096-6374 |
ispartof | Growth hormone & IGF research, 2013-10, Vol.23 (5), p.179-186 |
issn | 1096-6374 1532-2238 |
language | eng |
recordid | cdi_proquest_miscellaneous_1428272693 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Advanced Basic Science Animals Basal Ganglia - cytology Basal Ganglia - embryology Basal Ganglia - metabolism Cell Proliferation - drug effects Cell Survival - drug effects Cells, Cultured CNS development Embryo, Mammalian Endocrinology & Metabolism Female Growth hormone Growth Hormone - pharmacology Mice Mice, Inbred BALB C Neural precursor cells Neural Stem Cells - drug effects Neural Stem Cells - physiology Neurogenesis - drug effects Neurogenesis - genetics Pregnancy Receptors, Somatotropin - genetics Striatum |
title | Growth hormone (GH) is a survival rather than a proliferative factor for embryonic striatal neural precursor cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A40%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Growth%20hormone%20(GH)%20is%20a%20survival%20rather%20than%20a%20proliferative%20factor%20for%20embryonic%20striatal%20neural%20precursor%20cells&rft.jtitle=Growth%20hormone%20&%20IGF%20research&rft.au=Regalado-Santiago,%20Citlalli&rft.date=2013-10-01&rft.volume=23&rft.issue=5&rft.spage=179&rft.epage=186&rft.pages=179-186&rft.issn=1096-6374&rft.eissn=1532-2238&rft_id=info:doi/10.1016/j.ghir.2013.07.002&rft_dat=%3Cproquest_cross%3E1428272693%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1428272693&rft_id=info:pmid/23891194&rft_els_id=S109663741300066X&rfr_iscdi=true |